2012 IR News

2012.02.03	Consolidated Financial Results for the Thrid Quarter of Fiscal 2011
2012.01.23	Seikagaku Initiates a Phase II Clinical Trial in the United States for SI-614, Indicated for Treatment of Dry Eye	31KB
2012.01.05	Seikagaku Announces a Change in Sales Partner for SUPARTZ in the U.S.	45KB

In order to view the PDF files,
you need to have Adobe Reader 5.0 or later version installed.